Drug intelligence / Profile preview

E-GB-60

Development stage
Unknown
Lead developer
Ergon Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

E-GB-60 is an Ayurvedic herbal product developed and marketed by Ergon Pharmaceuticals, a company based in Bangladesh. The product contains 60 mg of *Ginkgo biloba* extract per capsule and is indicated for the treatment of cerebral insufficiency, including symptoms such as memory deficit, depression, and attention loss associated with Alzheimer's disease and multi-infarct dementia. Additionally, it is used to manage vertigo and tinnitus of vascular origin, as well as peripheral vascular diseases like intermittent claudication. Its primary mechanism of action involves the inhibition of platelet-activating factor (PAF) binding to platelets, which leads to reduced platelet aggregation and improved blood fluidity and microcirculation.

Brand names
E-GB-60E-GB60E-GB 60
Other names
Ginkgo biloba extract
02

Targets

PTAFR (Platelet-activating factor receptor)

Beyond the preview

Go deeper on E-GB-60.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E-GB-60.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call